[Use of the passive hemagglutination test for diagnosis of meningococcal infection]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|April 1, 1976
PubMed

Insights

Increased antibody titers to meningococcus group A were detected in patients with meningococcal infections using the passive hemagglutination test (PHAT). This diagnostic method aids in identifying meningococcal disease, particularly meningococcemia and meningitis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Context:

  • Meningococcus infections pose significant public health challenges.
  • Accurate and timely diagnosis is crucial for effective patient management.
  • Serological markers can aid in identifying the causative agent of bacterial meningitis and sepsis.

Purpose:

  • To evaluate the utility of the passive hemagglutination test (PHAT) for detecting antibodies against meningococcus group A.
  • To determine the correlation between increased antibody titers and clinical manifestations of meningococcal disease.

Summary:

  • A significant proportion of patients with meningococcus infection showed elevated antibody titers to meningococcus group A, as measured by PHAT.
  • The increase in antibody titers was most commonly observed in patients presenting with meningococcemia and meningitis.
  • These findings suggest PHAT is a valuable auxiliary diagnostic tool for confirming meningococcal etiology.

Impact:

  • The study highlights the potential of PHAT as a supportive diagnostic method in clinical settings.
  • Improved diagnostic capabilities can lead to earlier and more targeted treatment of meningococcal infections.
  • This research contributes to understanding the host immune response to meningococcal pathogens.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...